The most common form of genetic heart disease is hypertrophic cardiomyopathy (HCM), which is caused by variants in cardiac sarcomeric genes and leads to abnormal heart muscle thickening. Complications of HCM include heart failure, arrhythmia and sudden cardiac death. The dominant-negative c.1208G>A (p.R403Q) pathogenic variant (PV) in β-myosin (MYH7) is a common and well-studied PV that leads to increased cardiac contractility and HCM onset. In this study we identify an adenine base editor and single-guide RNA system that can efficiently correct this human PV with minimal bystander editing and off-target editing at selected sites. We show that delivery of base editing components rescues pathological manifestations of HCM in induced pluripotent stem cell cardiomyocytes derived from patients with HCM and in a humanized mouse model of HCM. Our findings demonstrate the potential of base editing to treat inherited cardiac diseases and prompt the further development of adenine base editor-based therapies to correct monogenic variants causing cardiac disease.
Base editing correction of hypertrophic cardiomyopathy in human cardiomyocytes and humanized mice / Chai A.C.; Cui M.; Chemello F.; Li H.; Chen K.; Tan W.; Atmanli A.; McAnally J.R.; Zhang Y.; Xu L.; Liu N.; Bassel-Duby R.; Olson E.N.. - In: NATURE MEDICINE. - ISSN 1078-8956. - ELETTRONICO. - 29:2(2023), pp. 401-411. [10.1038/s41591-022-02176-5]
Base editing correction of hypertrophic cardiomyopathy in human cardiomyocytes and humanized mice
Chemello F.;
2023
Abstract
The most common form of genetic heart disease is hypertrophic cardiomyopathy (HCM), which is caused by variants in cardiac sarcomeric genes and leads to abnormal heart muscle thickening. Complications of HCM include heart failure, arrhythmia and sudden cardiac death. The dominant-negative c.1208G>A (p.R403Q) pathogenic variant (PV) in β-myosin (MYH7) is a common and well-studied PV that leads to increased cardiac contractility and HCM onset. In this study we identify an adenine base editor and single-guide RNA system that can efficiently correct this human PV with minimal bystander editing and off-target editing at selected sites. We show that delivery of base editing components rescues pathological manifestations of HCM in induced pluripotent stem cell cardiomyocytes derived from patients with HCM and in a humanized mouse model of HCM. Our findings demonstrate the potential of base editing to treat inherited cardiac diseases and prompt the further development of adenine base editor-based therapies to correct monogenic variants causing cardiac disease.File | Dimensione | Formato | |
---|---|---|---|
Chai et al., HCM - Nature Med revision v3.pdf
Open Access dal 02/08/2023
Tipo:
Postprint
Licenza:
Licenza per accesso libero gratuito
Dimensione
8.08 MB
Formato
Adobe PDF
|
8.08 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.